Gambaran Persepsi Masyarakat Penerima Vaksin Covid-19 di Desa Penfui Timur RT 18
DOI:
https://doi.org/10.55123/sehatmas.v2i2.1485Keywords:
Perception, Vaccines, Covid-19Abstract
The Covid-19 vaccine is one of the government's breakthroughs to fight and deal with Covid-19 in the world, especially Indonesia. The goal of the Covid-19 vaccination is to reduce the spread of Covid-19, reduce the morbidity and mortality caused by Covid-19, achieve immunity and protect the public from Covid-19, so that it can protect society and the economy. This study aims to describe the Perception of the Community Recipient of the Covid-19 Vaccine in East Penfui Village Rt.18. This research was conducted using a type of qualitative research using a descriptive survey method. The population in this study is all the people in RT 18, East Penfui Village. The population of this research study is the people who live in RT 18, East Penfui Village with a total of 400 people and the sampling technique uses simple random sampling technique with a sample size of 200 people. The results showed that the majority of the people of RT 18, East Penfui Village believed in the safety and availability of the Covid-19 vaccine, namely 137 residents or 68.5%, while 63 residents (32.5%) were unsure about the safety and availability of the vaccine. Covid-19. the entire community of RT 18, East Penfui Village has received the Covid-19 vaccine under the brands Sinovac, Astrazeneca, Pfizer, Novavax, Moderna and with the complete dose, namely the first dose and the second dose (100%). The people of RT 18, East Penfui Village gave an unfavorable response or reaction to the addition of the third dose of the Covid-19 vaccine, namely 104 residents (52%). Suggestions for the Government Provide education about the importance of the Covid-19 vaccine and strive to foster a sense of trust, safety, and comfort in administering the Covid-19 vaccine.
Downloads
References
Arumsari, W., Desty, R. T., & Kusumo, W. E. G. (2021). Gambaran penerimaan vaksin COVID-19 di Kota Semarang. Indonesian Journal of Health Community, 2(1), 35-45.
DA Akhiryani, D. (2021). Gambaran Persepsi Tenaga Kesehatan Setelah Diberikan Vaksinasi Covid-19 Di Uptd Puskesmas Tanjung Lengkayap Kabupaten Ogan Komering Ulu Tahun 2021 (Doctoral dissertation, STIK Bina Husada Palembang).
Kemenkes RI Dirjen P2P (2020) ‘Kementerian Kesehatan Republik Indonesia, Tentang Petunjuk Teknis Pelaksanaan Vaksinasi Dalam Rangka
Kemenkes RI (2020b) ‘Situasi terkini Perkembangan Novel Coronavirus (Covid-19)’.
Kompas.com (2021a) 8 vaksin Covid-19 di uni dan Efikasinya Melindungi dari Virus Corona. Available at: https://www.kompas.com/sains/read/2021/05/21/190200023/8-vaksin-covid-19-di-dunia-dan-efikasinya-melindungi-dari-virus-corona?page=all. (Accessed: 03 Oktober 2022).
Notoatmodjo, S. (2010)Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta
Rachman, F. F. and Pramana, S. (2020) ‘Analisis Sentimen Pro dan Kontra Masyarakat Indonesia tentang Vaksin COVID-19 pada Media Sosial Twitter’, 8(2), pp. 100–109.
Suwanti, I., & Darsini, D. (2022). Peningkatan Persepsi Masyarakat Tentang Program Nasional Vaksinasi Booster Covid-19. Jurnal Bhakti Civitas Akademika, 5(2), 18-26.
Shafa, A., & Sriwidodo, S. (2021). Microneedle: Teknologi Baru Penghantar Vaksin COVID-19. Majalah Farmasetika, 6(1), 85-98.
Sugiyono. (2016). Statistika untuk Penelitian. Bandung. Alfabeta.
WHO (2020a) ‘Coronavirus disease 2019 ( COVID-19 ) Situation Report –70’, (March).
Al-Hinai, M., Al-Muqbali, M., Al-Moqbali, A., Gowri, V., & Al-Maniri, A. (2013). Effects of pre-pregnancy body mass index and gestational weight gain on low birth weight in Omani infants: A case-control study. Sultan Qaboos University Medical Journal, 13(3), 386–391.
Apriani, E., Subandi, A., & Mubarok, A. K. (2021). Hubungan Usia Ibu Hamil, Paritas dan Usia Kehamilan dengan Kejadian BBLR di RSUD Cilacap. Tens: Trends of Nursing Science, 2(1), 45-52.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Ferdinandus Ju, Marylin Susanti Junias, Indriati A. Tedju Hinga
This work is licensed under a Creative Commons Attribution 4.0 International License.
Hak cipta pada setiap artikel adalah milik penulis.
Penulis mengakui bahwa SEHATMAS (Jurnal Ilmiah Kesehatan Masyarakat) sebagai publisher yang mempublikasikan pertama kali dengan lisensi Creative Commons Attribution 4.0 International License.
Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain, seperti: dikirim ke respository institusi penulis, publikasi kedalam buku, dan lain-lain. Dengan mengakui bahwa naskah telah terbit pertama kali pada SEHATMAS (Jurnal Ilmiah Kesehatan Masyarakat).